Literature DB >> 16563587

Impact of ciprofloxacin in the human-flora-associated (HFA) rat model: comparison with the HFA mouse model.

Agnès Perrin-Guyomard1, Jean-Michel Poul, Michel Laurentie, Pascal Sanders, A Haydée Fernández, Mary Bartholomew.   

Abstract

The ecological impact of different doses of ciprofloxacin was investigated in an experimental germ-free rat model into which human fecal flora was inoculated. Animals received oral doses (gavage) of 0, 0.25, 2.5, and 25 mg/kg body weight (bw) of ciprofloxacin once daily for 5 weeks. All doses of ciprofloxacin significantly reduced aerobic populations. Elimination of Enterobacteriaceae and reduction of bifodibacteria were noticed in the group treated with 25 mg/kg of the antibiotic. The rest of the intestinal flora was not affected. These effects were reversible after the treatment ended. The percentage of resistant enterococci increased in rats treated with 2.5 and 25 mg/kg; however, this increase was not statistically significant. There was a significant (P < 0.05) emergence of ciprofloxacin-resistant Bacteroides fragilis group with 25 mg/kg bw, which is equivalent to a human therapeutic dosage of the antibiotic. The MIC values and the percentage of resistance remained elevated 2 weeks after the end of treatment in this anaerobic population. Although sub-populations of enterococci and Enterobacteriaceae showed decreased susceptibility after ciprofloxacin administration, resistance was not evident. The ability of an exogenous strain of Salmonella to colonize the intestine of animals treated with 25 mg/kg of ciprofloxacin confirmed that the drug disrupted the colonization barrier effect of the indigenous flora at the high dose level tested. No changes in the metabolic parameters occurred during the antibiotic treatment. The results obtained in the HFA rat model were similar to those obtained in our previous study using the HFA mice model where ciprofloxacin at 0.125, 1.25, and 12.5 mg/kg bw induced a decrease of enterococci and Enterobacteriaceae populations. The high dose of ciprofloxacin also induced a decrease in bifidobacteria counts, an increase in levels of resistant B. fragilis group and a significant (P < 0.05) disruption of the colonization resistance of the barrier flora in HFA mice.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16563587     DOI: 10.1016/j.yrtph.2006.02.002

Source DB:  PubMed          Journal:  Regul Toxicol Pharmacol        ISSN: 0273-2300            Impact factor:   3.271


  4 in total

1.  In vitro model of colonization resistance by the enteric microbiota: effects of antimicrobial agents used in food-producing animals.

Authors:  R Doug Wagner; Shemedia J Johnson; Carl E Cerniglia
Journal:  Antimicrob Agents Chemother       Date:  2008-01-28       Impact factor: 5.191

2.  Comparative diversity analysis of gut microbiota in two different human flora-associated mouse strains.

Authors:  Xiaojing Zhang; Benhua Zeng; Zhiwei Liu; Zhenlin Liao; Wenxai Li; Hong Wei; Xiang Fang
Journal:  Curr Microbiol       Date:  2014-05-08       Impact factor: 2.188

3.  Transfer of plasmid-mediated CTX-M-9 from Salmonella enterica serotype Virchow to Enterobacteriaceae in human flora-associated rats treated with cefixime.

Authors:  S Faure; A Perrin-Guyomard; J M Delmas; P Chatre; M Laurentie
Journal:  Antimicrob Agents Chemother       Date:  2009-11-09       Impact factor: 5.191

4.  Evaluation of an oral subchronic exposure of deoxynivalenol on the composition of human gut microbiota in a model of human microbiota-associated rats.

Authors:  Manuel J Saint-Cyr; Agnès Perrin-Guyomard; Paméla Houée; Jean-Guy Rolland; Michel Laurentie
Journal:  PLoS One       Date:  2013-11-18       Impact factor: 3.240

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.